Patents by Inventor John A. Myers
John A. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9763966Abstract: Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: September 4, 2015Date of Patent: September 19, 2017Assignee: Warsaw Orthopedic, Inc.Inventors: William F. McKay, Christopher M Hobot, Danielle L. Biggs, Katara Shaw, John Myers Zanella, Vanja Margareta King, Stephen Mark Cox, Kathy L. Remsen
-
Patent number: 9585872Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: January 29, 2015Date of Patent: March 7, 2017Assignee: Warsaw Orthopedic, Inc.Inventors: John Myers Zanella, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, Phillip Edward McDonald, Vanja Margareta King, William F. McKay, Kathy L. Remsen
-
Patent number: 9452609Abstract: In one embodiment, an ink cartridge comprises an outer housing that defines an interior space adapted to contain ink and an air vent adapted to enable air to pass into and out of the interior space and a dividing wall provided within the interior space, the dividing wall separating the interior space into a first chamber and a second chamber, the dividing wall defining a passage through which air within the first chamber can pass into the second chamber and out of the cartridge through the air vent when the air within the first chamber expands.Type: GrantFiled: May 13, 2008Date of Patent: September 27, 2016Assignee: Hewlett-Packard Development Company, L.P.Inventor: John A Myers
-
Publication number: 20160213630Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: ApplicationFiled: March 31, 2016Publication date: July 28, 2016Inventors: Jared T. Wilsey, Danielle L. Clay, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
-
Patent number: 9301946Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: December 2, 2011Date of Patent: April 5, 2016Assignee: Warsaw Orthopedic, Inc.Inventors: Jared T. Wilsey, Danielle L. Biggs, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
-
Patent number: 9289409Abstract: Effective treatments of pain and/or inflammation for extended periods of time are provided. Through the administration of an effective amount of sulindac or a pharmaceutically acceptable salt thereof at or near a target site, one can relieve pain and/or inflammation caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days, at least twenty-five days. In some embodiments, the relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: March 27, 2009Date of Patent: March 22, 2016Assignee: Warsaw Orthopedic, Inc.Inventors: John Myers Zanella, Vanja M King, Christopher M Hobot, S Mark Cox, Danielle Biggs, Katara Shaw, William F McKay, Kathy L Remsen
-
Publication number: 20160022704Abstract: Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: ApplicationFiled: September 4, 2015Publication date: January 28, 2016Inventors: William F. McKay, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, John Myers Zanella, Vanja Margareta King, Stephen Mark Cox, Kathy L. Remsen
-
Publication number: 20150251031Abstract: Fire suppression systems (10) for vehicles and industrial applications including arrangements of an input bus (24) and output bus (26) coupled to a centralized controller (20) to provide for automatic and manual detection of a fire (H) and manual and automatic system actuation in response to the fire. The arrangements further provide for system information regarding the status and operation of the system components. Additionally, the arrangement of system components provide for expandability and programmability to configure the system for the protection of multiple and variable hazards (H) using customized or programmed detection and/or actuation. The systems include configured connectors (25) and colour coded schemes to facilitate system installation.Type: ApplicationFiled: September 23, 2013Publication date: September 10, 2015Inventors: Derek M. Sandahl, Brian L. Counts, Marvin B. Fernstrum, Chad Ryczek, Saul Escalante-Ortiz, John T. Werth, Gregory J. Lilley, David R. Strehlow, Anthony J. Kreft, Thomas John Myers, John S. Bushert, Richard J. Hackl, Marvin D. Thorell
-
Patent number: 9125917Abstract: Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: March 27, 2009Date of Patent: September 8, 2015Assignees: Warsaw Orthopedic, Inc., Medtronic, Inc.Inventors: William F McKay, Christopher M Hobot, Danielle Biggs, Katara Shaw, John Myers Zanella, Vanja M King, Stephen Mark Cox, Kathy L Remsen
-
Publication number: 20150231431Abstract: Fire suppression systems for vehicles and industrial applications including arrangements of an input bus and output bus coupled to a centralized controller to provide for automatic and manual detection of a fire and manual and automatic system actuation in response to the fire. The arrangements further provide for system information regarding the status and operation of the system components. Additionally, the arrangement of system components provide for expandability and programmability to configure the system for the protection of multiple and variable hazards using customized or programmed detection and/or actuation. The systems include configured connectors and color coded schemes to facilitate system installation.Type: ApplicationFiled: September 23, 2013Publication date: August 20, 2015Inventors: Derek M. Sandahl, Brian L. Counts, Marvin B. Fernstrum, Chad Ryczek, Saul Escalante-Ortiz, John T. Werth, Gregory J. Lilley, David R. Strehlow, Anthony J. Kreft, Thomas John Myers, John S. Bushert, Richard J. Hackl, Marvin D. Thorell
-
Publication number: 20150174104Abstract: Disclosed herein are systems and methods for contributing to the local treatment of pain. More specifically, the disclosed systems and methods contribute to the local treatment pain by inhibiting the NF?B family of transcription factors.Type: ApplicationFiled: March 2, 2015Publication date: June 25, 2015Inventors: Eric Neal Burright, Lisa Lynn Shafer, William F. McKay, John Myers Zanella
-
Publication number: 20150148396Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: ApplicationFiled: January 29, 2015Publication date: May 28, 2015Inventors: John Myers Zanella, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, Phillip Edward McDonald, Vanja Margareta King, William F. McKay, Kathy L. Remsen
-
Patent number: 8956641Abstract: Effective treatments of pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease.Type: GrantFiled: April 13, 2009Date of Patent: February 17, 2015Assignee: Warsaw Orthopedic, Inc.Inventors: John Myers Zanella, William F. McKay, Vanja Margareta King, Christopher M. Hobot, Keith R. Hildebrand
-
Patent number: 8946277Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.Type: GrantFiled: April 8, 2009Date of Patent: February 3, 2015Assignee: Warsaw Orthopedic, Inc.Inventors: John Myers Zanella, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, Phillip Edward McDonald, Vanja Margareta King, William F. McKay, Kathy L. Remsen
-
Publication number: 20150007821Abstract: The present disclosure pertains to a pressure support system configured to provide pressure support therapy to a subject, wherein the pressure support system comprises a subject interface heater configured to controllably heat a pressurized flow of breathable gas to a target temperature that is offset from a baseline temperature. The breathable gas baseline temperature target offset ensures the gas delivered to the subject is delivered at a comfortable temperature and/or humidity level that does not cause airway dryness or result in condensed water in the subject interface. In one embodiment, the pressure support system comprises one or more of a pressure generator, a subject interface, a subject interface heater, one or more subject interface temperature sensors, one or more baseline temperature sensors, one or more general sensors, a humidifier, a user interface, a processor, electronic storage, and/or other components.Type: ApplicationFiled: February 7, 2013Publication date: January 8, 2015Inventors: Jeffrey Ronald Winski, Richard Charles Dombrowski, JR., David John Myers, Michael Joseph Mussallem, Kevin Michael Bowen, Brian John Bunofsky, Benjamin Alfred Giovannelli, Jason Hauris Daschbach
-
Patent number: 8889173Abstract: Effective treatments of pain and/or inflammation are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation.Type: GrantFiled: April 15, 2009Date of Patent: November 18, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: John Myers Zanella, Sara D. Waynick
-
Publication number: 20140336162Abstract: This invention provides for using a locally delivered low dose of a corticosteroid to treat pain caused by any inflammatory disease including sciatica, herniated disc, stenosis, mylopathy, low back pain, facet pain, osteoarthritis, rheumatoid arthritis, osteolysis, tendonitis, carpal tunnel syndrome, or tarsal tunnel syndrome. More specifically, a locally delivered low dose of a corticosteroid can be released into the epidural space, perineural space, or the foramenal space at or near the site of a patient's pain by a drug pump or a biodegradable drug depot.Type: ApplicationFiled: July 28, 2014Publication date: November 13, 2014Inventors: William F. McKay, John Myers Zanella, Christopher M. Hobot
-
Publication number: 20140139224Abstract: A stray-wire sensor includes a vertical magnetic gradiometer (VMG) carried over the surface by ground vehicles or by low-flying aircraft. The VMG has a spot of sensitivity on the ground which stays nadir to the VMG itself. A Faraday shield surrounding the VMG screens out the near field electric dipole signals, and a ferrite rod core and winding inside act as an antenna sensitive to the near-field magnetic dipole signals which radiate from horizontal lying stray wires on the ground surface in the dirt of hidden by ground cover. The VMG depends on it being moved around over the ground so that magnetic signal gradients and reversals can be measured point-by-point. The nadir points which fall over a point along a long horizontal wire will express characteristic signatures in the signal gradients and phase reversals measureable in the antenna.Type: ApplicationFiled: January 15, 2014Publication date: May 22, 2014Applicant: Stolar Research CorporationInventors: Gerald L. Stolarczyk, Tito L. Sanchez, Chance Dain Valentine, John A. Myers, Beaux L. Beard, Ernest M. Salazar, Richard Brewster Main
-
Patent number: 8702677Abstract: Drug depot delivery devices and methods are provided for delivering one or more drug depots to one or more sites beneath the skin of a patient with or without repositioning the cannula. The device has a cannula capable of insertion to the site beneath the skin of the patient and one or more side port openings for delivering a drug depot. The side port openings are spaced a distance from the blunt tip, which will allow the user to implant at a set distance from a nerve. The device may also include an electronic monitor for detecting the proximity of the tip of the cannula to a nerve. In some embodiments, a method of delivering a drug depot is provided by detecting the nerve and delivering the drug depot at or near the nerve.Type: GrantFiled: October 31, 2008Date of Patent: April 22, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: Thomas A. Simonton, Sean M. Haddock, John Myers Zanella, William F. McKay
-
Patent number: 8623396Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of immediate release bupivacaine or lidocaine and a sustained release clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days or longer.Type: GrantFiled: December 2, 2011Date of Patent: January 7, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: Jonathan K. Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, Danielle L. Clay, Jared T. Wilsey, John Myers Zanella